Imugene Limited IUGNF
Set alert
At close · Oct 30
- YTD
- -76.23%
- 1 year
- -71.91%
- Open
- 0.0352
- Prev close
- 0.0618
- Mkt cap
- 34.24M
- Vol
- 14.35K
- Avg vol
- 22.17K
- EPS
- -0.22
- P/E
- 0.00
More statistics
- Low
- 0.0352
- High
- 0.0352
News
3 months ago proactiveinvestors.com
Figma shares rise as Bank of America resumes coverage with a ‘Buy’ rating
Figma (NYSE:FIG) was reinstated with a ‘Buy’ rating and a $30 price objective by Bank of America, with the firm arguing that artificial intelligence is...
3 months ago proactiveinvestors.com
Imugene raises $11.1 million to advance azer-cel after complete responses in early cohort
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) is raising about A$11.12 million before costs through a two-tranche placement, strengthening its balance sheet as...
3 months ago proactiveinvestors.com
Shell flags 'significantly higher' gas trading and sells South Africa business - UPDATE
Shell PLC (LSE:SHEL, NYSE:SHEL) shares jumped over 2% after it said stronger trading and improved refining margins should support second-quarter...
4 months ago proactiveinvestors.com
Imugene reports second BTKi cohort response - ICYMI
Imugene Ltd (ASX:IMU, OTC:IUGNF) earlier this week reported a second complete response in the concurrent Bruton Tyrosine Kinase inhibitor, or BTKi, cohort...
4 months ago proactiveinvestors.com
Imugene CEO details azer-cel trial milestone - ICYMI
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) earlier this week reported the first complete response in the concurrent Bruton Tyrosine Kinase inhibitor, or...
4 months ago proactiveinvestors.com
Anthropic clears export hurdle for Fable 5, easing a threat to its IPO story
The most striking thing about the standoff that ended on Tuesday is not that it ended, but that it happened at all: a US government blocking a US company...
4 months ago proactiveinvestors.com
Imugene reports second complete response in azer-cel BTKi cohort
Just a day after reporting the first complete response in the concurrent Bruton Tyrosine Kinase inhibitor (BTKi) cohort of its ongoing Phase 1b azer-cel...
4 months ago proactiveinvestors.com
Fed may adopt leaner communications strategy under Warsh, says Deutsche Bank
Federal Reserve communications are likely to become shorter, less reliant on forward guidance and more focused on longer-term economic narratives under new...
4 months ago proactiveinvestors.com
Nasdaq leads Wall Street higher, Dow Jones notches new record as second quarter ends
4:15pm: Best quarter since 2020 Wall Street has wrapped up its best quarter since 2020, with the Dow Jones adding another 0.3% on Friday to close at a fresh...
4 months ago proactiveinvestors.com
Imugene reports first complete response in azer-cel BTKi cohort
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has reported the first complete response in the concurrent Bruton Tyrosine Kinase inhibitor (BTKi) cohort of its...
4 months ago proactiveinvestors.com
FDA Fast Track opens new path for Imugene's Azer-cel - ICYMI
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) earlier this week announced that the US Food and Drug Administration (FDA) granted Fast Track Designation to its...
4 months ago proactiveinvestors.com
Inside Biotech: FDA fast-track nod sharpens focus on Imugene's off-the-shelf CAR T ambitions
CAR T therapies have transformed treatment options for some blood cancers. They have also exposed one of cell therapy's biggest practical limitations: time....
4 months ago proactiveinvestors.com
Thor Energy lifted by hydrogen project update
Thor Energy PLC (AIM:THR, OTCQB:THORF, ASX:THR) shares lifted 25%, to 0.75p, after it said Phase-2 survey work at its HY-Range project in South Australia...
5 months ago proactiveinvestors.com
Imugene showcases Azer-Cel progress at ASCO - ICYMI
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) earlier this week highlighted encouraging clinical progress for its Azer-Cel program after presenting new data at...
5 months ago proactiveinvestors.com
Dow Jones, Nasdaq close at record levels as Trump says US-Iran peace talks are advancing
4:15pm: Peace optimism boosts stocks US stocks finished Monday’s session higher on renewed hopes a peace deal would be struck between the US and Iran, with...
5 months ago proactiveinvestors.com
Costco's value strategy, membership growth support outlook after strong quarter, says Jefferies
Costco Wholesale Corporation (NASDAQ:COST, XETRA:CTO) delivered a strong fiscal third quarter performance, with its value-focused strategy, membership...
5 months ago proactiveinvestors.com
Anthropic confidentially files to go public in the US
Anthropic said on Monday it has confidentially filed for a US initial public offering, positioning the artificial intelligence company for what could become...
5 months ago proactiveinvestors.com
Iovance Biotherapeutics pushes cell therapy platform into solid tumor market
Iovance Biotherapeutics (NASDAQ:IOVA) said it has obtained clearance of an Investigational New Drug application for IOV-5001, extending its next-generation...
5 months ago proactiveinvestors.com
Small Cap Watch: commercial expansion updates drive news flow
The S&P/ASX Small Ordinaries Index continued its strong run, climbing 2.28% on Friday to close at 3,501.80 and gaining 2.19% over the past five trading...
5 months ago proactiveinvestors.com
Imugene presents azer-cel data at ASCO as trial expands into new cohort
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has presented new Phase 1b data for its azer-cel cell therapy at the 2026 American Society of Clinical Oncology...